Syntegra is unlocking the promise of real-world evidence by employing a groundbreaking machine learning model — the Syntegra Medical Mind — to enable low-burden access to privacy-preserved and equitable synthetic health data, increasing the value of data for those who have it and providing access for those who need it. Synthetic data matches the statistical accuracy of the underlying data without linking to any actual patients, fully protecting patient privacy. Syntegra’s ever-growing model is built from the statistical patterns of structured healthcare data to serve the diverse needs of our customers, including health systems, life sciences, health tech, payers and clinical research organizations. Gain immediate access to patient-level data via our Synthetic Data API today. Users can leverage our data to accelerate data science and analytics, build predictive models, generate synthetic control groups for clinical trials and so much more. Syntegra is backed by well-established investment firms, including Sweat Equity Ventures, Hike Ventures, Impact Venture Capital, Village Global, Wisconn Valley Ventures and Innovation Global Capital.